Logo-apb
Adv Pharm Bull. 2023;13(2): 275-282. doi: 10.34172/apb.2023.030
PMID: 37342385        PMCID: PMC10278227

Mini Review

Chitosan and Its Structural Modifications for siRNA Delivery

Mona Y. Al-Absi 1 ORCID, Anna Eleonora Caprifico 1 ORCID, Gianpiero Calabrese 1 * ORCID

Cited by CrossRef: 1


1- Karayianni M, Sentoukas T, Skandalis A, Pippa N, Pispas S. Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives. Pharmaceutics. 2023;15(7):1849 [Crossref]
2- Singh P, Singh M, Singh B, Sharma K, Kumar N, Singh D, Klair H, Mastana S. Implications of siRNA Therapy in Bone Health: Silencing Communicates. Biomedicines. 2024;12(1):90 [Crossref]